Accuray and RaySearch Formed Radiation Therapy Partnership
The two companies have entered a definitive agreement to jointly market online adaptive radiation therapy solutions.
Updated on Sept. 25, 2026 in Cancer
Accuray and RaySearch have established a global collaboration to advance the adoption of online adaptive radiation therapy. The companies aim to integrate their technology to enhance treatment personalization and clinical efficiency.
Why it matters
This partnership leverages complementary capabilities in photon-based radiation therapy and software to accelerate innovation in cancer care. By connecting clinical systems, the collaboration seeks to improve how healthcare providers deliver precise, individualized patient treatments.
The partnership focuses on integrating the Radixact platform with RayStation and RayCare technology. Accuray has purchased specific software licenses to support the initial commercialization of these joint solutions.
The players
Accuray
Accuray is a radiation oncology company that develops, manufactures, and sells radiotherapy systems to treat tumors.
RaySearch
RaySearch is a medical technology company that specializes in software solutions for integrated cancer care.
The details
The collaboration combines Accuray's radiation therapy hardware with RaySearch's planning and workflow software systems. While the initial integration prioritizes the Radixact platform, the companies intend to extend these adaptive therapy capabilities to the CyberKnife platform in the future.
Timeline
September 11, 2026: Accuray and RaySearch announced their definitive collaboration agreement.
The Big Picture
The collaboration marks a strategic shift in the deployment of the Radixact platform to include advanced adaptive software integrations.
This collaboration aims to provide patients with more personalized radiation therapy options through improved clinical workflows. Enhanced adaptive capabilities may lead to more precise treatment planning, allowing for real-time adjustments during a patient's course of care.
The takeaway
This agreement underscores a growing industry trend of hardware and software developers teaming up to streamline complex cancer treatments. Clinicians and patients can expect improved access to advanced, adaptive radiation technologies as these systems become more integrated.
Further reading
For more information on the latest developments in oncology, visit our Cancer section.
